Phillip Fleshner, MD
Colon & Rectal Surgery · West Hollywood, CANPI 1881695286
Payments from drug & device makers
Across 254 payments — averaging $1590.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$340K
- Olympus Corporation$25K
- Applied Medical Resources Corporation$25K
- Intuitive Surgical$5K
- Vioptix Inc$3K
- Davol Inc.$2K
- plus $5K from 18 others
Across 58 payments — averaging $3176.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$184K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 155 | $340,031 |
| Olympus Corporation | 19 | $24,831 |
| Applied Medical Resources Corporation | 2 | $24,500 |
| Intuitive Surgical | 7 | $4,797 |
| Vioptix Inc | 2 | $2,526 |
| Davol Inc. | 2 | $2,272 |
| Olympus Corporation Of The Americas | 8 | $1,666 |
| AbbVie | 7 | $942 |
| Medtronic(2 entities) | 16 | $807 |
| Prescient Surgical | 14 | $786 |
| BD | 1 | $400 |
| Axonics, Inc. | 3 | $108 |
| Merck | 4 | $67 |
| Baxter Healthcare | 1 | $60 |
| Biotissue Holdings Inc. | 2 | $48 |
| Ferring Pharmaceuticals Inc. | 1 | $42 |
| Integra Lifesciences Corporation | 2 | $41 |
| Acell, Inc. | 2 | $34 |
| Vertex | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Boston Scientific | 1 | $23 |
| Teleflex LLC | 1 | $21 |
| Cook Medical LLC | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
How this compares
$404,090 in reported general payments places this provider in the 95th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other colon & rectal surgery in West Hollywood
- Beth MooreWest Hollywood$28K
- Sang LeeLos Angeles$2.6M
- Pamela LeeSan Diego$544K
- Hueylan ChernSan Francisco$328K
- Joseph CarmichaelOrange$179K
- Samuel EisensteinSan Diego$147K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Kyle CologneLos Angeles$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.